Caribou Biosciences Inc

+1.94 (+7.99%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.57B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$16.5 Million
Adjusted EPS-$0.12
See more estimates
10-Day MA$25.99
50-Day MAN/A
200-Day MAN/A
See more pivots

Caribou Biosciences Inc Stock, NASDAQ:CRBU

2929 7th Street, Suite 105, Berkeley, California 94710
United States of America
Phone: +1.510.982.6030
Number of Employees: 67


Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.